Автор туралы ақпарат

КАНЕСТРИ, Вероника Геннадиевна

Шығарылым Бөлім Атауы Файл
№ 3 (2012) Articles THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
№ 1 (2013) Articles USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
№ 2 (2013) Articles THE HEPATITIS C VIRUS PROTEASE INHIBITOR TELAPREVIR IN THERAPY REGIMENS FOR CHRONIC HEPATITIS C IN PATIENTS WITH HIV INFECTION
№ 6 (2013) Articles CONTRIBUTION OF A FIXED-DOSE ABACAVIR/LAMIVUDINE COMBINATION TO IMPROVING TREATMENT COMPLIANCE IN HIV-INFECTED PATIENTS
№ 1 (2015) Articles Hepatotoxicity of antiretroviral therapy in HIV-infected patients
№ 1 (2015) Articles A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
№ 2 (2015) Articles EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
№ 6 (2015) Articles HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
№ 2 (2011) Articles THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
Том 10, № 3 (2020) Articles THE PROBLEM OF BODY WEIGHT GAIN IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY
Том 10, № 4 (2020) Articles Impact of the organism’s genetic traits on the development of secondary and concomitant diseases in patients with HIV infection
Том 11, № 3 (2021) Articles Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
Том 11, № 4 (2021) Articles The clinical course of HIV/ COVID-19 co-infection and approaches to its therapy
Том 11, № 4 (2021) Articles Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
Том 12, № 3 (2022) Articles Comparative analysis of clinical and laboratory outcomes in HIV-infected patients vaccinated and not vaccinated against COVID-19
Том 12, № 3 (2022) Articles The efficiency and safety of ART after switching patients to the combined Russian NRTI phosphaladine in combination with elsulfavirine

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>